Dermatomyositis is a skin disorder characterized by a number of clinical signs and symptoms. Dermatomyositis is an uncommon disease marked by muscle weakness and a distinctive skin rash. Because of similarities in signs, symptoms and treatment, dermatomyositis is often discussed in conjunction with polymyositis. Both conditions fall into the category of inflammatory muscle diseases — "myo" means "muscles" in Greek; "itis" means "inflamed." "Derma," means "skin." Although dermatomyositis may occur at any age, it mostly affects adults in their late 40s to early 60s or children between 5 and 15 years of age. Women have dermatomyositis more often than men do. Those with dermatomyositis have a higher risk of cancer with an increased risk of mortality due to visceral involvement. Cutaneous involvement has no vital impact on mortality but considerably affects the quality of life of the patients and can resist to classical therapies.
Many classification schemes are available, based on internal organ involvement, presence of circulating autoantibodies and additional symptoms characteristic for other connective tissue diseases. The prognosis of the individual patient depends on the involvement of internal organs and the characterization of circulating autoantibodies.
Juvenile Dermatomyositis
Juvenile dermatomyositis is a rare disease of childhood with significant
morbidity. Although the mortality and morbidity has improved over recent
decades, it is still a chronic disease for a significant proportion of children
with juvenile dermatomyositis. There is a lack of controlled trials in both
adult and juvenile dermatomyositis and hence alternative treatments are
difficult to find.The treatment of juvenile dermatomyositis often involves
methotrexate and aggressively tapered steroids.
Dermatomyositis symptom
The most common signs and symptoms of dermatomyositis include: A
violet-colored or dusky red rash, most commonly on the face, eyelids, and areas
around your nails, knuckles, elbows, knees, chest and back; Progressive muscle
weakness, particularly in the muscles closest to the trunk, such as those in
hips, thighs, shoulders, upper arms and neck. This weakness is symmetrical,
affecting both the left and right sides of the body; difficulty swallowing (dysphagia);
muscle pain or tenderness.
Polymyositis and Dermatomyositis
Interstitial lung disease is a common complication of polymyositis and
dermatomyositis, and accounts for a significant proportion of their morbidity
and mortality because of the resistance to therapeutic agents including
corticosteroids. They may be associated with other autoimmune diseases such as
myasthenia gravis, Hashimoto's thyroiditis, systemic sclerosis and Waldenstrom's
Macroglobulinaemia. Damage to capillaries would seem to be an underlying
pathology in dermatomyositis.
Dermatomyositis treatment
There are patients with rapidly developing subsets of dermatomyositis and those with
slowly progressive disease. Therefore treatment has to be adjusted for the
disease severity. Sometimes high dosages of corticosteroids in combination with
immunosuppressive agents or immunoglobulins are required.
Tacrolimus is an immunosuppressive agent and topical tacrolimus is
used for the treatment of atopic dermatitis and has been occasionally used to
treat skin involvement of some systemic inflammatory diseases. Topical
tacrolimus seems to be
a therapeutic alternative for resistant skin lesions of dermatomyositis.
Cause of dermatomyositis
Scietists are still trying to find the cause of dermatomyositis. Dermatomyositis
belongs to a group of conditions called inflammatory myopathies. Viral
infections and underlying malignancies are possible mechanisms to trigger this
autoimmune disease.
Pregnancy and dermatomyositis
Polymyositis and dermatomyositis can occur in pregnancy. The role of
pregnancy in the disease is unknown. The outcome of the pregnancy seems to
reflect the severity of the disease. The more active the myositis during the
pregnancy, the greater the chance of fetal loss.
Dermatomyositis questions
Q. Do you think any supplements can improve or make dermatomyositis worse? I
take 5-HTP and
lipoic acid.
A. I am not aware of any research with supplements and
dermatomyositis.